Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-15-009534
Filing Date
2015-12-09
Accepted
2015-12-09 14:39:55
Documents
1
Period of Report
2015-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4186
  Complete submission text file 0000899243-15-009534.txt   5657
Mailing Address C/O ACHILLION PHARMACEUTICALS INC. 300 GEORGE STREET NEW HAVEN CT 06511
Business Address
Graves Kurt (Reporting) CIK: 0001406337 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36199 | Film No.: 151278191

Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Issuer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations